Literature DB >> 12007165

Estimating an EQ-5D population value set: the case of Japan.

Aki Tsuchiya1, Shunya Ikeda, Naoki Ikegami, Shuzo Nishimura, Ikuro Sakai, Takashi Fukuda, Chisato Hamashima, Akinori Hisashige, Makoto Tamura.   

Abstract

Quality adjustment weights for quality-adjusted life years (QALYs) are available with the EQ-5D Instrument, which are based on a survey that quantified the preferences of the British public. However, the extent to which this British value set is applicable to other, especially non-European, countries is yet unclear. The objectives of this study are (a) to compare the valuations obtained in Japan and Britain, and (b) to explore a local Japanese value set. A diminished study design is employed, where 17 hypothetical EQ-5D health states are evaluated as opposed to 42 in the British study. The official Japanese version of the instrument and the Time Trade-Off method are used to interview 543 members of the public. The results are: firstly, the evaluations obtained in Japan and those from Britain differ by 0.24 on average on a [-1, +1] scale, and mean absolute error (MAE) in predicting the Japanese preferences with the British value set is 0.23. Secondly, comparable regressions suggest that the two peoples have systematically different preference structures (p<0.001 for 8 of 12 coefficients; F-test). Thirdly, using alternative models, the predictions are improved so that the local Japanese value set achieves MAE in the order of 0.01. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 12007165     DOI: 10.1002/hec.673

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  202 in total

1.  Population norms for the EQ-5D index scores using Singapore preference weights.

Authors:  Edimansyah Abdin; Mythily Subramaniam; Janhavi Ajit Vaingankar; Nan Luo; Siow Ann Chong
Journal:  Qual Life Res       Date:  2014-11-14       Impact factor: 4.147

Review 2.  The development and use of quality-of-life measures to evaluate health outcomes in Japan.

Authors:  Shunichi Fukuhara; Naoki Ikegami; George W Torrance; Shuzo Nishimura; Michael Drummond; François Schubert
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

3.  A decision chart for assessing and improving the transferability of economic evaluation results between countries.

Authors:  Robert Welte; Talitha Feenstra; Hans Jager; Reiner Leidl
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

4.  Does the EQ-5D reflect lost earnings?

Authors:  Carl Tilling; Marieke Krol; Aki Tsuchiya; John Brazier; Job van Exel; Werner Brouwer
Journal:  Pharmacoeconomics       Date:  2012-01       Impact factor: 4.981

5.  The English and Chinese versions of the five-level EuroQoL Group's five-dimension questionnaire (EQ-5D) were valid and reliable and provided comparable scores in Asian breast cancer patients.

Authors:  Chun Fan Lee; Raymond Ng; Nan Luo; Nan Soon Wong; Yoon Sim Yap; Soo Kien Lo; Whay Kuang Chia; Alethea Yee; Lalit Krishna; Celest Wong; Cynthia Goh; Yin Bun Cheung
Journal:  Support Care Cancer       Date:  2012-06-06       Impact factor: 3.603

6.  Preliminary findings of an investigation into the relationship between national culture and EQ-5D value sets.

Authors:  Henry Bailey; Paul Kind
Journal:  Qual Life Res       Date:  2010-05-23       Impact factor: 4.147

7.  Do Portuguese and UK health state values differ across valuation methods?

Authors:  Lara N Ferreira; Pedro L Ferreira; Donna Rowen; John E Brazier
Journal:  Qual Life Res       Date:  2011-05       Impact factor: 4.147

8.  Development and Validation of a Patient-Reported Outcome Measurement for Symptom Assessment in Cirrhotic Ascites.

Authors:  Myrte Neijenhuis; Tom J G Gevers; Thomas D Atwell; Tim J Gunneson; Amanda C Schimek; Wietske Kievit; Joost P H Drenth; Patrick S Kamath
Journal:  Am J Gastroenterol       Date:  2018-03-20       Impact factor: 10.864

9.  Cognitive function is maintained in noninstitutionalized elderly Japanese requiring care with high levels of health-related quality of life.

Authors:  Kaori Kitamura; Kazutoshi Nakamura; Kimiko Ueno; Tomoko Nishiwaki
Journal:  Environ Health Prev Med       Date:  2016-10-03       Impact factor: 3.674

10.  Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China.

Authors:  Yuanxi Jia; Li Li; Fuqiang Cui; Dongliang Zhang; Guomin Zhang; Fuzhen Wang; Xiaohong Gong; Hui Zheng; Zhenhua Wu; Ning Miao; Xiaojin Sun; Li Zhang; Jingjing Lv; Feng Yang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.